Delivery Order SPE2DB20D1047-SPE2DB25FF58L

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,228.50, is for the delivery of BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product, to be completed by May 1, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $1,042.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BUTALB-ACETAMIN-CAF-COD 50-325 100S medication to support military healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,017.77, is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S, a prescription medication product. The delivery order is a firm fixed price contract with a completion date of July 25, 2024. AmerisourceBergen, the prime contractor, does not have a small business set-aside for this award. The contract is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,096.11, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,312.40 with a firm fixed price and an ultimate completion date of April 2, 2025. The contract covers the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S medical products, which are likely prescription pharmaceuticals. The award is not designated as a set-aside contract....
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,176.38 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUTALB-ACETAMIN-CAFF 50-325-40 100S medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency Troop Support Medical awarded a $237 firm fixed price delivery order to Amerisourcebergen Drug Corp for 90 bottles of Butalbital-Aspirin-Caffeine capsules. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order is scheduled to be fulfilled on September 19th through the 20th of 2023 under the parent company Amerisourcebergen Corporation's corporate office division contract vehicle. No subcontractors or set...
The Defense Logistics Agency awarded a $25,050 firm fixed-price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under the contract, Amerisourcebergen will provide 4562018550 BUTALB-ACETAMIN-CAFF 50-325-40 100S, described as acetaminophen, butalbital, and caffeine tablets, to be delivered to a facility in Conshohocken, Pennsylvania. The single order is for a one-day period of performance from August 31, 2023 to September 1, 2023. As the DLA supports the...
This federal contract award, valued at $4,033.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type. The award has an ultimate completion date of August 22, 2024. No set-aside designation is mentioned. Amerisourcebergen Drug Corp...
This delivery order from the Defense Logistics Agency to Amerisourcebergen Drug Corp is valued at $120.24 to supply 4561483473 BUTALB-ACETAMIN-CAFF 50-325-40 100S from July 12-13, 2023. Amerisourcebergen Drug Corp will perform as the prime contractor under a firm fixed price contract. The parent company, Amerisourcebergen Corporation, will support delivery from its Conshohocken, Pennsylvania distribution center to the DLA. No subcontractors or set aside designations were specified. This order is...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF58L
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,061.27, is for the delivery of 4,568,139,083 units of the pharmaceutical product Butalbital-Aspirin-Caffeine Capsules. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract supports the DLA's medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/4/25, 9:56 AM